中国生化药物杂志
中國生化藥物雜誌
중국생화약물잡지
CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS
2015年
8期
23-26,30
,共5页
石磊%穆懿%马虎%李列%柏玉举%陈红
石磊%穆懿%馬虎%李列%柏玉舉%陳紅
석뢰%목의%마호%리렬%백옥거%진홍
放射性肺损伤%肺宁颗粒%转化生长因子-β1%白介素-1%白介素-6
放射性肺損傷%肺寧顆粒%轉化生長因子-β1%白介素-1%白介素-6
방사성폐손상%폐저과립%전화생장인자-β1%백개소-1%백개소-6
radiation-induced lung injury%Feining granule%transforming growth factor-β1%interleukin-1%interleukin-6
目的:探讨肺宁颗粒防治大鼠急性放射性肺损伤( radiation induced lung injur ,RILI)及对细胞因子转化生长因子β1(transforming growth factor-β1,TGF-β1)、白介素-1(interleukin-1,IL-1)、白介素-6(interleukin-6,IL-6)的影响。方法选取105只雌性SD大鼠,根据随机数字表法将大鼠分成7组,分别为正常组、模型组、地塞米松组(阳性药物)、肺宁颗粒低剂量组、肺宁颗粒中剂量组、肺宁颗粒高剂量组、肺宁颗粒预防组,每组各15只。除去正常组,余各组均全胸接受X线单次照射15 Gy,DT30Gy/2f/1w。肺宁颗粒预防组于放射治疗前1周起开始灌胃肺宁颗粒;余组在照射后48 h起灌胃。于2、4、6周分别采用随机法每组取出5只大鼠,处死后取右肺,采用免疫组化法检测放疗后不同时段各组大鼠肺组织TGF-β1、IL-1、IL-6的含量。结果放疗后第2、4、6周模型组大鼠肺组织TGF-β1、IL-1、IL-6强表达,显著高于正常组( P<0.05)。经肺宁颗粒干预后各时间点大鼠肺组织中TGF-β1、IL-1、IL-6表达显著低于同时点模型组(P<0.05),且呈一定浓度依赖性。但肺宁颗粒高、中、低剂量组TGF-β1、IL-1、IL-6表达均不同程度高于地塞米松组(P<0.05),而肺宁颗粒预防组上述指标表达低于地塞米松组(P<0.05)。结论肺宁颗粒能够通过降低TGF-β1、IL-1、IL-6的表达防治放射性肺损伤。肺宁颗粒各治疗组疗效不如地塞米松,但肺宁颗粒预防的疗效优于地塞米松。
目的:探討肺寧顆粒防治大鼠急性放射性肺損傷( radiation induced lung injur ,RILI)及對細胞因子轉化生長因子β1(transforming growth factor-β1,TGF-β1)、白介素-1(interleukin-1,IL-1)、白介素-6(interleukin-6,IL-6)的影響。方法選取105隻雌性SD大鼠,根據隨機數字錶法將大鼠分成7組,分彆為正常組、模型組、地塞米鬆組(暘性藥物)、肺寧顆粒低劑量組、肺寧顆粒中劑量組、肺寧顆粒高劑量組、肺寧顆粒預防組,每組各15隻。除去正常組,餘各組均全胸接受X線單次照射15 Gy,DT30Gy/2f/1w。肺寧顆粒預防組于放射治療前1週起開始灌胃肺寧顆粒;餘組在照射後48 h起灌胃。于2、4、6週分彆採用隨機法每組取齣5隻大鼠,處死後取右肺,採用免疫組化法檢測放療後不同時段各組大鼠肺組織TGF-β1、IL-1、IL-6的含量。結果放療後第2、4、6週模型組大鼠肺組織TGF-β1、IL-1、IL-6彊錶達,顯著高于正常組( P<0.05)。經肺寧顆粒榦預後各時間點大鼠肺組織中TGF-β1、IL-1、IL-6錶達顯著低于同時點模型組(P<0.05),且呈一定濃度依賴性。但肺寧顆粒高、中、低劑量組TGF-β1、IL-1、IL-6錶達均不同程度高于地塞米鬆組(P<0.05),而肺寧顆粒預防組上述指標錶達低于地塞米鬆組(P<0.05)。結論肺寧顆粒能夠通過降低TGF-β1、IL-1、IL-6的錶達防治放射性肺損傷。肺寧顆粒各治療組療效不如地塞米鬆,但肺寧顆粒預防的療效優于地塞米鬆。
목적:탐토폐저과립방치대서급성방사성폐손상( radiation induced lung injur ,RILI)급대세포인자전화생장인자β1(transforming growth factor-β1,TGF-β1)、백개소-1(interleukin-1,IL-1)、백개소-6(interleukin-6,IL-6)적영향。방법선취105지자성SD대서,근거수궤수자표법장대서분성7조,분별위정상조、모형조、지새미송조(양성약물)、폐저과립저제량조、폐저과립중제량조、폐저과립고제량조、폐저과립예방조,매조각15지。제거정상조,여각조균전흉접수X선단차조사15 Gy,DT30Gy/2f/1w。폐저과립예방조우방사치료전1주기개시관위폐저과립;여조재조사후48 h기관위。우2、4、6주분별채용수궤법매조취출5지대서,처사후취우폐,채용면역조화법검측방료후불동시단각조대서폐조직TGF-β1、IL-1、IL-6적함량。결과방료후제2、4、6주모형조대서폐조직TGF-β1、IL-1、IL-6강표체,현저고우정상조( P<0.05)。경폐저과립간예후각시간점대서폐조직중TGF-β1、IL-1、IL-6표체현저저우동시점모형조(P<0.05),차정일정농도의뢰성。단폐저과립고、중、저제량조TGF-β1、IL-1、IL-6표체균불동정도고우지새미송조(P<0.05),이폐저과립예방조상술지표표체저우지새미송조(P<0.05)。결론폐저과립능구통과강저TGF-β1、IL-1、IL-6적표체방치방사성폐손상。폐저과립각치료조료효불여지새미송,단폐저과립예방적료효우우지새미송。
Objective To investigate Feining granule on prevention and treatment of rat with radiation-induced lung injur ( RILI) and its effect on cytokine transforming growth factor-β1(TGF-β1), interleukin-1 (IL-1), interleukin-6 (IL-6).Methods 105 SD female rats were selected, according to random number table, and divided into seven groups: normal group, model group, dexamethasone group(positive drug), Feining granule low-dose group (FN low-dose group), FN medial-dose group, FN high-dose group and FN prevention group, 15 rats in each group.Except for normal group, all remaining groups received the X-ray irradiation of 15Gy, DT30Gy/2f/1w.FN prevention group were intragastric infused with FN granule one week before irradiation, and the other groups 48 h after irradiation.Five rats were sacrificed randomly at 2, 4, 6 weeks respectively, and right lung tissues were taken out.The contents of TGF-β1, IL-1 and IL-6 were detected by immunohistochemical method.ResuIts TGF-β1, IL-1 and IL-6 contents in lung tissue of model group at 2, 4, 6 weeks were higher than those of normal group (P<0.05).The above indicators after treated by Feining granule were lower than those of model group at each time (P<0.05),with a concentration-dependence manner to some extent.The above indicators in FN high-, medial-and low-dose group were higher than those in dexamethasone group (P<0.05), to some extent.However, the above indicators in FN prevention group were lower than those in dexamethasone group ( P<0.05 ) .ConcIusion Feining granule could prevent and cure radiation induced lung injury through decreasing TGF-β1, IL-1 and IL-6 content.The efficacy of dexamethasone is stronger than FN treatment groups, but is weaker than FN prevention.